Jmems 2016 2524542
Jmems 2016 2524542
Jmems 2016 2524542
Abstract— In this paper, a smart pill for local drug delivery is its high patient acceptance and low cost [2]. Smart pills for
presented. The pill is designed to achieve local therapy on gas- drug delivery offer a number of significant opportunities for
trointestinal tissue thanks to a novel drug delivery system (DDS). pharmaceutical industries because they may be used in a wide
The DDS consists of a miniature electrolytic pump. This micro-
fabricated pump is ideal for medical applications because of its range of applications and enable therapies not possible with
low power consumption, compatibility with small size batteries, conventional means. For instance, they allow the treatment
integrability on miniaturized systems, and biocompatibility. The of locally active diseases along the gastrointestinal system,
actuation principle of the micropump relies on the electrolysis of such as gastroesophageal reflux (GERD), esophageal cancer
a water-based solution, which is separated from a drug reservoir or inflammatory bowel diseases (IBD), intestinal cancer and
by an elastic membrane. The electrolytically produced gases pres-
surize the electrolytic solution reservoir, causing the deflection of irritable bowel syndrome [3].
the elastic membrane. Such deflection, in turn, forces the drug In fact, therapies for those pathologies include biological
out of its reservoir through a nozzle. In order to measure and drugs that are very expensive and require large intravenous
monitor the membrane displacement, and therefore the volume infusions (e.g. infliximab, used in IBD, requires infusion
of drug ejected, a strain gauge sensor has been prepared using of 5 mg per kilogram of body weight from every
a conductive thermoplastic nanocomposite elastomer (CTPE).
The sensor is fixed on the deformable membrane. The CTPE 2 to 8 weeks [4]). The use of smart pills for local delivery
shows high sensitivity and allows to customize the resistance can drastically reduce the doses (∼50-60 μl are required)
of the device to obtain low power consumption. Thus, by and consequently the whole costs of the therapy. Swallowable
measuring the current though the electrolytic cell and monitoring drug delivery systems for local treatment bring also many
membrane deformation, the volume of the ejected drug can be advantages and opportunities for personalized therapies
controlled. [2015-0200]
(e.g. the region of interest can vary from patient to patient
Index Terms— Smart pill, drug delivery systems, miniature and for the same patient overtime), effectiveness (e.g. specific
electrolytic pump, conductive thermoplastic nanocomposite dose), better management of disease (e.g. site-specific drug
elastomer (CTPE) sensor, closed loop control.
delivery with minimal side-effects) reduced doses and
correspondingly lower costs for the health systems.
I. I NTRODUCTION The development of miniaturized fluidic systems and in
particular of (low-cost and biocompatible) micro pumps is
S MART pills are ingestible miniaturized electro-
mechanical devices [1], representing a point of con-
vergence between biomedical technology, medicine and the
functional to the improvement of the performance of drug
delivery systems (DDS).
pharma industry. Electronics, sensors and miniature robotic In general, the activation of a drug delivery system can
technology can give access, analyze and manipulate the body be triggered by different types of parameters, such as tem-
from the inside. In particular, smart pills for drug delivery are perature, chemical (i.e. pH) or electrical parameters (i.e.
an emerging technology; many different approaches to local impedance), that are medical indexes for the detection of
drug delivery have been proposed, including transcutaneous physiological conditions alterations. We chose to use on the
and implantable means. Anyhow, swallowable smart pills for capsule an electrical parameter, in particular an impedance
drug delivery are receiving increasing attention as the oral sensor, because biological tissues have different response
one is still the preferred route for drug administration, due to to different frequencies of stimulation and types of tissue
can be discriminated to their response. In addition, altered
Manuscript received July 14, 2015; revised January 24, 2016; accepted electrical responses could reveal pathological conditions [5].
January 26, 2016. Subject Editor C. Ahn.
R. Goffredo, E. Guglielmelli, and D. Accoto are with the Biomedical Furthermore, impedance measurement is less susceptible to
Robotics and Biomicrosystems Laboratory, Università Campus Bio-Medico external factors such as food or liquid ingestion than pH. Thus,
di Roma, Rome 00128, Italy (e-mail: [email protected]; activation of the drug delivery system according to the readings
[email protected]; [email protected]).
A. Pecora and L. Maiolo are with the Institute for Microelectronics of an impedance sensor, makes the smart pill appropriate for
and Microsystems, Consiglio Nazionale delle Ricerche, Rome 00133, Italy local treatment of site-specific active pathologies. Regardless,
(e-mail: [email protected]; [email protected]). the sensing system developed has been described by authors
A. Ferrone is with Institute for Microelectronics and Microsystems,
Consiglio Nazionale delle Ricerche, Rome 00133, Italy, and also with the in [6], so this paper will focus on the therapeutic functions of
Science Department, Università degli Studi Roma Tre, Rome 00146, Italy the capsule, i.e. the DDS. The design and fabrication of the
(e-mail: [email protected]). capsule is described, and the drug delivery system, comprising
Color versions of one or more of the figures in this paper are available
online at http://ieeexplore.ieee.org. an electrolytic microfabricated pump is presented and tested.
Digital Object Identifier 10.1109/JMEMS.2016.2524542 Furthermore, in order to enable the future design of a closed
1057-7157 © 2016 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
See http://www.ieee.org/publications_standards/publications/rights/index.html for more information.
This article has been accepted for inclusion in a future issue of this journal. Content is final as presented, with the exception of pagination.
on the reservoir. The membrane is then cut and the CTPE An interesting property of the CTPE is that it can work in
sensor is fixed to the membrane, which can then be glued four different regimes (fig. 5) according to the pre-treatment to
to the electrolytic solution reservoir prefilled with the saline which the material is subjected. So the stripe of CTPE, used as
solution. a sensor, underwent a pre-strain procedure to force the device
The electrolytic pump is mounted in the frontal lobe of to work in the recoverable damage regime (regime III).
the capsule. The displacement of the membrane, due to gases This regime was selected to obtain a sensor with repeatable
production, forces the release of the drug (about 50 μl are characteristics and a customized value of resistance that can
required for the DDS) (fig. 4). guarantee low power consumption, necessary for the applica-
tion of the device in a DDS.
The procedure consisted of stretching the CTPE stripe to
C. Assembling
break the bonds inside the polymer and stabilize the resistance
The 3D printed capsule can be easily mechanically assem- to a percentage of the desired strain, thus obtaining a length
bled in few steps. on average three times the starting one and a resistance
Firstly, the drug delivery system is assembled: R0 ∼ 80k.
- The drug reservoir is filled from the bottom while the Electrical connections are provided at the edge of the stripe
dispensing hole on the drug reservoir is sealed. in order to read its resistance. During the experiments the
- The pre-filled electrolytic solution reservoir is fitted in variation of resistance was continuously measured with a
the drug reservoir that constitutes the frontal lobe of the multimeter (Hp1444a) and plotted in a Matlab Inc. interface.
capsule. CTPE has been chosen as the optimal candidate for con-
Then, the drug delivery system is mounted on the stant monitoring of the membrane deformations because it
remaining part of the capsule: shows a better behavior for low speed deformations, such
- the assembly (drug reservoir and electrolytic pump) is as those involved in electrolytic reactions (10 ÷ 20 μm/s),
locked by clamping on the central part of the cap- in comparison to other viscoelastic materials and nanocom-
sule a thin collar that prevents the electrolytic solution posites (e.g. PDMS). These materials, in fact, generally suffer
reservoir from sliding backward, while it cannot slide from a high drift, show very slow recovery times and cannot
forward because it mechanically fits the frontal lobe of track movements for low strain rates. Furthermore, a CTPE
the capsule. sensor can track deformations from 0.07% to 20%, while
- External electrodes are fixed on both sides of the central maintaining a good sensitivity to small movements and accept-
part of the capsule body. Finally, able hysteresis [11].
- The electronic board and the battery are put in place Preliminary strain tests on the conductive thermoplastic
in the central part of the capsule. nanocomposite have been carried out by cyclically stretching
- The capsule is closed by locking the second lobe on the the device along a single direction using a materials testing
rear part of the central body. machine (Instron 3365) at a speed of 100μm/sec at different
applied strain (5%, 10% and 20%). In such tests the number of
III. M ODELING AND T ESTING iterations is set to five. Considering the expected application,
this value corresponds to an overestimation of the number of
A. Strain Sensor Properties and Characterization actual membrane deformations that would occur in case of
The CTPE material was provided by Kraiburg TPE intermittent drug releases. The smallest hysteresis is shown
GmbH & Co: this material exhibits a density of 1.07 g/cm3, for 5% strain (fig. 6).
a hardness of 84 shA, resistance to traction of 10.9 N/mm2 Since the amplitude of the hysteresis cycle is propor-
and a wide working temperature range (−40÷110 °C). The tional to strain-rate, hysteresis can be neglected at sufficiently
strain sensor is cut from the CTPE material in a stripe low deformation speed as those involved in the electrolytic
(30 × 1 × 0.2 mm) with a value of resistance Rtpe ∼ 15 k. reaction.
This article has been accepted for inclusion in a future issue of this journal. Content is final as presented, with the exception of pagination.
Fig. 8. Membrane CAD and deflection model of the membrane due to the
applied pressure.
TABLE I
S IMULATIONS R ESULTS
Fig. 14. Setup 3D CAD: it presents a central cavity (A) of the same shape
Fig. 12. Key steps for gas production measurement.
of the electrolytic solution reservoir with a hole in the bottom to allow the
connection to a tube for air insufflation (B). On the surface of the setup the
PDMS membrane is laid and the CTPE fixed (C).
Sincethe electrical charge Q is the time integral of current I
τ
(Q = 0 I (t) dt), the amount of gases produced can be As the volume of gas produced, Vgas , is calculated from
evaluated by monitoring the current through the electrodes. the measured current at the electrodes and the variation of
To this purpose, an interface was implemented in Labview resistance is correlated to the volumetric displacement of the
(National Instrument) running on a PC equipped with a membrane, the latter can be adopted in the control system of
DAQ NI USB-6009 ADC/DAC converter card. An analog- the drug delivery (fig. 13).
to-digital line recorded the current through the pump when a Furthermore, the integration of the strain sensor, that moni-
constant 3V voltage was applied to the electrodes. Current tors the membrane deflections, makes the drug delivery system
flowing through the electrolytic cell is influenced by the appropriate for the dispensing of different kind of liquid drugs.
concentration of ions and increases over time (Fig.11). In fact, the measure is not influenced, for example, by the
The amount of gas produced in the pump, Vgas , is propor- fluid viscosity as will happen with a control based on a direct
tional to the electrical charge Q according to (3) and can be pressure measurement inside the capsule.
calculated following the logical flow diagram shown in Fig 12. The closed-loop control implemented is fundament for the
The number of moles of electrons produced in 120 sec, correct functioning of the smart pill as it is supposed to be
ne-, is ne-=Q/F=5.5 μmol, corresponding to 7.3 μmol of gas able to reject all possible failures during navigation. Possible
(164 μl of gas in STP conditions). malfunctions could be caused by the external pressure exerted
The relation between the current measured at the electrodes by gastric fluids on the capsule and in particular on the nozzle.
and the flow rate of the released drug is shown in eq. (4) as The monitoring of the membrane deformations permits to
a function of the time t: identify any cases of nozzle plugging. The measure of the
VST P τ current at the electrodes allows a double check for cases when
Q (t) = I (t) dt (4)
z Ft 0 the gas is produced in the electrolytic pump but no deformation
considering the flow diagram in fig 12, the volume of of the membrane is read because the nozzle is plugged by
gas produced is expressed as Vgas = n gas · VST external forces or cases when the membrane breaks and no
P where, τ
I (t )dt deflection is detected by the CTPE sensor while the electrolytic
VST P = 22.414l and the moles of gas n gas = 0 z F are reaction is active.
calculated from the Faraday’s law (eq. 3), taking into account
that the electrical charge Q is the time integral of current I .
E. Experimental Tests on the Sensor and
So the flow rate calculated is 1,36 μl/s.
Electrolytic Pump Sensorization
In order to compare simulation results with real membrane
D. Membrane Sensorization deflections and the corresponding displaced volumes a setup
Sensorization of the membrane allows to measure the over- was fabricated. CTPE sensor resistances were measured in
all deformations of the membrane, as needed to achieve a order to obtain a correspondence between the value of resis-
closed-loop control of the amount of drug released. tance measured by the sensor and volumetric displacement
In fact, once known the information about the sensor resis- related to the amount of drug to deliver.
tance variations and the current increase due to the electrolytic The dedicated setup (fig. 14) was 3D printed in order to
reaction, the drug release can be controlled. have a stable structure for repeated tests. This setup permitted
This article has been accepted for inclusion in a future issue of this journal. Content is final as presented, with the exception of pagination.
TABLE II
S ENSOR R ESPONSE AT D IFFERENT V OLUMETRIC D ISPLACEMENTS
Fig. 20. Resistance vs. displaced volume during the electrolytic reaction.